Balance Sheet - Ascendis Pharma A/S (ASND)
$ (Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 | Dec-11 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 615.78 | 559.54 | 399.44 | 735.46 | 682.06 | 718.80 | 598.11 | 277.86 | 195.35 | 180.33 | 119.65 | 50.17 | 19.43 | 14.54 | 15.68 |
| Accounts receivable, net | 157.63 | 166.28 | 35.87 | 11.91 | 2.20 | 0.39 | 0.80 | 0.01 | 0.19 | 0.29 | 1.06 | 1.29 | 1.71 | 5.72 | 2.02 |
| Inventories | 301.40 | 295.61 | 208.93 | 130.67 | 75.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other current assets | 33.70 | 39.43 | 58.48 | 45.43 | 46.22 | 20.95 | 12.26 | 15.04 | 9.10 | 3.34 | 4.94 | 1.70 | 0.06 | 0.44 | 0.27 |
| Total current assets | 1,108.51 | 1,060.86 | 702.72 | 923.47 | 805.89 | 740.13 | 611.17 | 292.91 | 204.63 | 183.96 | 125.65 | 53.16 | 21.20 | 20.70 | 17.97 |
| Total non-current assets | 193.50 | 118.63 | 122.87 | 166.27 | 279.04 | 239.66 | 65.57 | 26.06 | 6.35 | 6.11 | 6.12 | 5.51 | 5.50 | 4.71 | 4.84 |
| Total assets | 1,302.02 | 1,179.50 | 825.59 | 1,089.74 | 1,084.92 | 979.79 | 676.73 | 318.97 | 210.98 | 190.07 | 131.77 | 58.67 | 26.70 | 25.41 | 22.82 |
| Total current liabilities | 1,068.94 | 907.86 | 736.51 | 716.78 | 100.36 | 52.80 | 47.99 | 38.92 | 23.77 | 13.46 | 11.45 | 12.86 | 20.40 | 23.85 | 22.37 |
| Total non-current liabilities | 395.83 | 377.34 | 234.78 | 109.61 | 100.93 | 88.28 | 31.63 | 26.64 | 23.77 | 13.17 | 11.45 | 12.86 | 19.99 | 23.83 | 0.21 |
| Total liabilities | 1,464.77 | 1,285.20 | 971.28 | 826.39 | 201.29 | 141.08 | 79.62 | 38.92 | 23.77 | 13.46 | 11.45 | 12.86 | 20.40 | 23.85 | 22.59 |
| Total stockholders' equity | -162.75 | -105.71 | -145.70 | 263.35 | 883.64 | 838.71 | 597.11 | 280.05 | 187.21 | 176.61 | 120.33 | 45.81 | 6.30 | 1.56 | 0.23 |
| Common shares outstanding | 61 | 58 | 56 | 56 | 55 | 51 | 47 | 41 | 34 | 27 | 24 | 17 | 11 | 11 | |
Show Quarterly Balance Sheet
Balance Sheet - Ascendis Pharma A/S (ASND)
$ (Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | Dec-17 | Sep-17 | Jun-17 | Mar-17 | Dec-16 | Sep-16 | Jun-16 | Mar-16 | Dec-15 | Sep-15 | Jun-15 | Mar-15 | Dec-14 | Sep-14 | Jun-14 | Mar-14 | Dec-13 | Sep-13 | Jun-13 | Mar-13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 573.42 | 615.78 | 539.09 | 494.05 | 517.92 | 559.54 | 625.52 | 258.70 | 320.24 | 399.44 | 455.43 | 431.10 | 585.74 | 735.46 | 919.81 | 955.15 | 978.70 | 682.06 | 858.29 | 550.63 | 664.71 | 718.80 | 929.80 | 471.56 | 598.11 | 598.11 | 658.66 | 690.36 | 696.66 | 277.86 | 310.33 | 352.60 | 348.41 | 195.35 | 206.29 | 127.32 | 157.65 | 180.33 | 74.53 | 90.75 | 101.87 | 119.65 | 128.25 | 137.85 | 153.45 | 50.17 | 7.91 | 11.76 | 19.43 | 19.43 | 0.00 | 0.00 | 14.54 |
| Accounts receivable, net | 196.81 | 157.63 | 147.25 | 110.45 | 66.69 | 166.28 | 33.10 | 49.16 | 41.09 | 35.87 | 26.79 | 20.21 | 16.12 | 11.91 | 6.66 | 4.37 | 5.81 | 2.20 | 0.53 | 0.39 | 0.06 | 0.39 | 2.72 | 7.03 | 5.41 | 0.80 | 3.05 | 2.58 | 0.00 | 0.01 | 0.02 | 0.02 | 0.03 | 0.19 | 0.44 | 0.45 | 0.38 | 0.29 | 0.42 | 0.39 | 0.89 | 1.06 | 0.74 | 1.35 | 0.85 | 1.29 | 1.17 | 2.10 | 1.71 | ||||
| Inventories | 314.67 | 301.40 | 302.02 | 303.38 | 293.07 | 295.61 | 265.43 | 251.20 | 232.68 | 208.93 | 189.13 | 167.92 | 150.85 | 130.67 | 103.98 | 101.32 | 92.44 | 75.41 | 55.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Other current assets | 38.61 | 33.70 | 29.42 | 45.08 | 43.81 | 39.43 | 49.69 | 68.26 | 70.10 | 58.48 | 61.57 | 58.45 | 57.13 | 45.43 | 49.46 | 51.25 | 44.14 | 46.22 | 42.50 | 33.22 | 22.51 | 20.95 | 21.08 | 20.06 | 7.65 | 12.26 | 10.99 | 12.48 | 19.11 | 15.04 | 16.63 | 9.04 | 9.31 | 9.10 | 9.01 | 8.27 | 8.42 | 3.34 | 5.63 | 5.40 | 3.80 | 4.94 | 6.37 | 3.06 | 1.50 | 1.70 | 1.05 | 0.60 | 0.06 | ||||
| Total current assets | 1,123.51 | 1,108.51 | 1,017.78 | 952.96 | 921.49 | 1,060.86 | 973.74 | 627.32 | 664.11 | 702.72 | 732.93 | 677.68 | 809.85 | 923.47 | 1,079.90 | 1,112.10 | 1,121.08 | 805.89 | 956.59 | 584.25 | 687.27 | 740.13 | 953.60 | 491.62 | 611.17 | 611.17 | 669.65 | 702.83 | 715.78 | 292.91 | 326.99 | 361.66 | 357.76 | 204.63 | 215.74 | 136.04 | 166.44 | 183.96 | 80.57 | 96.55 | 106.56 | 125.65 | 135.36 | 142.26 | 155.80 | 53.16 | 10.12 | 14.45 | 19.43 | 21.20 | 14.54 | ||
| Total non-current assets | 881.86 | 193.50 | 136.97 | 134.95 | 139.95 | 118.63 | 120.04 | 130.98 | 138.39 | 122.87 | 140.29 | 146.15 | 156.43 | 166.27 | 193.52 | 214.74 | 256.17 | 279.04 | 248.65 | 267.60 | 278.04 | 239.66 | 92.52 | 68.98 | 65.57 | 65.57 | 65.31 | 64.33 | 46.16 | 26.06 | 8.25 | 7.21 | 7.07 | 6.35 | 6.30 | 6.36 | 6.32 | 6.11 | 6.18 | 6.19 | 6.12 | 6.12 | 5.91 | 5.85 | 5.48 | 5.51 | 5.61 | 5.67 | -19.43 | 5.50 | -14.54 | ||
| Total assets | 2,005.37 | 1,302.02 | 1,154.75 | 1,087.90 | 1,061.44 | 1,179.50 | 1,093.78 | 758.30 | 802.50 | 825.59 | 873.21 | 823.82 | 966.27 | 1,089.74 | 1,273.42 | 1,326.83 | 1,377.25 | 1,084.92 | 1,205.23 | 851.85 | 965.31 | 979.79 | 1,046.12 | 560.61 | 676.73 | 676.73 | 734.96 | 767.16 | 761.94 | 318.97 | 335.23 | 368.86 | 364.83 | 210.98 | 222.04 | 142.40 | 172.76 | 190.07 | 86.75 | 102.73 | 112.68 | 131.77 | 141.26 | 148.11 | 161.28 | 58.67 | 15.73 | 20.12 | 26.70 | ||||
| Total current liabilities | 1,127.94 | 1,068.94 | 986.48 | 935.00 | 885.51 | 907.86 | 838.46 | 847.74 | 798.97 | 736.51 | 212.76 | 192.27 | 198.36 | 171.27 | 142.84 | 115.13 | 95.36 | 100.36 | 116.12 | 70.30 | 72.93 | 52.80 | 64.43 | 54.37 | 47.99 | 47.99 | 42.53 | 60.62 | 32.07 | 38.92 | 31.03 | 36.64 | 17.41 | 23.77 | 19.89 | 15.94 | 17.94 | 13.46 | 12.35 | 11.83 | 10.77 | 11.45 | 9.55 | 12.38 | 12.09 | 12.86 | 13.23 | 15.98 | 20.40 | ||||
| Total non-current liabilities | 388.95 | 395.83 | 342.34 | 340.47 | 365.74 | 377.34 | 352.65 | 231.70 | 241.71 | 234.78 | 733.89 | 566.71 | 600.71 | 655.12 | 679.03 | 603.86 | 609.08 | 100.93 | 95.55 | 94.06 | 89.57 | 88.28 | 30.11 | 29.09 | 31.63 | 31.63 | 31.50 | 31.46 | 13.21 | 26.64 | 31.02 | 36.61 | 17.41 | 23.77 | 19.69 | 15.63 | 17.59 | 13.17 | 12.23 | 11.68 | 10.66 | 11.45 | 9.55 | 12.38 | 12.09 | 12.86 | 12.74 | 19.99 | |||||
| Total liabilities | 1,516.89 | 1,464.77 | 1,328.83 | 1,275.47 | 1,251.25 | 1,285.20 | 1,191.10 | 1,079.43 | 1,040.68 | 971.28 | 946.65 | 758.98 | 799.07 | 826.39 | 821.87 | 718.99 | 704.43 | 201.29 | 211.67 | 164.36 | 162.49 | 141.08 | 94.54 | 83.46 | 79.62 | 79.62 | 74.03 | 92.08 | 45.28 | 38.92 | 31.03 | 36.64 | 17.41 | 23.77 | 19.89 | 15.94 | 17.94 | 13.46 | 12.35 | 11.83 | 10.77 | 11.45 | 9.55 | 12.38 | 12.09 | 12.86 | 13.23 | 15.98 | 20.40 | ||||
| Total stockholders' equity | 488.48 | -162.75 | -174.08 | -187.57 | -189.81 | -105.71 | -97.32 | -321.13 | -238.18 | -145.70 | -73.43 | 64.84 | 167.20 | 263.35 | 451.55 | 607.84 | 672.82 | 883.64 | 993.56 | 687.49 | 802.82 | 838.71 | 951.59 | 477.14 | 597.11 | 597.11 | 660.93 | 675.08 | 716.66 | 280.05 | 304.21 | 332.23 | 347.41 | 187.21 | 202.15 | 126.47 | 154.83 | 176.61 | 74.40 | 90.91 | 101.91 | 120.33 | 131.72 | 135.73 | 149.19 | 45.81 | 2.50 | 4.14 | 6.30 | 6.30 | 1.56 | ||
| Common shares outstanding | 65 | 61 | 61 | 64 | 60 | 60 | 59 | 57 | 57 | 57 | 56 | 56 | 56 | 56 | 56 | 56 | 57 | 54 | 55 | 54 | 54 | 54 | 53 | 48 | 48 | 48 | 48 | 47 | 43 | 43 | 42 | 42 | 39 | 39 | 33 | 33 | 32 | 32 | 25 | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 17 | 11 | 11 | 11 | 11 | 11 | 11 |